Form 4: Amphastar Pharmaceuticals CFO William J. Peters Reports Stock Option Exercise and Sale

William J. Peters, CFO, EVP & Treasurer of Amphastar Pharmaceuticals, exercised stock options and sold shares on November 6, 2024, according to a Form 4 filing with the SEC.

Summary

• On November 6, 2024, William J. Peters, the CFO, EVP & Treasurer of Amphastar Pharmaceuticals, exercised employee stock options to acquire 7,426 shares of common stock at a price of $13.03 per share.
• Simultaneously, Peters sold 7,426 shares of common stock at a price of $52.05 per share.
• These transactions were executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2024.
• Following these transactions, Peters directly owns 94,103 shares of Amphastar Pharmaceuticals common stock and 23,674 derivative securities.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of insider trading activity. The transactions are part of a pre-planned trading strategy, so it doesn't necessarily indicate a positive or negative outlook.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like the CFO in this case, trade their company's stock. It provides transparency into insider transactions.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership.
• The transactions do not appear to have any impact on employees, customers, suppliers, or creditors.

Key Dates